HomeCompareOASMY vs QSR

OASMY vs QSR: Dividend Comparison 2026

OASMY yields 676.00% · QSR yields 3.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OASMY wins by $681598.71M in total portfolio value
10 years
OASMY
OASMY
● Live price
676.00%
Share price
$0.00
Annual div
$0.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$681598.74M
Annual income
$527,962,365,518.27
Full OASMY calculator →
QSR
QSR
● Live price
3.40%
Share price
$73.90
Annual div
$2.51
5Y div CAGR
-0.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$386.99
Full QSR calculator →

Portfolio growth — OASMY vs QSR

📍 OASMY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOASMYQSR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OASMY + QSR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OASMY pays
QSR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OASMY
Annual income on $10K today (after 15% tax)
$57,460.00/yr
After 10yr DRIP, annual income (after tax)
$448,768,010,690.53/yr
QSR
Annual income on $10K today (after 15% tax)
$288.70/yr
After 10yr DRIP, annual income (after tax)
$328.94/yr
At 15% tax rate, OASMY beats the other by $448,768,010,361.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OASMY + QSR for your $10,000?

OASMY: 50%QSR: 50%
100% QSR50/50100% OASMY
Portfolio after 10yr
$340799.38M
Annual income
$263,981,182,952.62/yr
Blended yield
77.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QSR right now

OASMY
No analyst data
Altman Z
-19.4
Piotroski
0/9
QSR
Analyst Ratings
27
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$81.57
+10.4% upside vs current
Range: $71.00 — $90.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OASMY buys
0
QSR buys
0
No recent congressional trades found for OASMY or QSR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOASMYQSR
Forward yield676.00%3.40%
Annual dividend / share$0.00$2.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.8%
Portfolio after 10y$681598.74M$24.7K
Annual income after 10y$527,962,365,518.27$386.99
Total dividends collected$669076.90M$3.7K
Payment frequencyquarterlyquarterly
SectorStockStock

Year-by-year: OASMY vs QSR ($10,000, DRIP)

YearOASMY PortfolioOASMY Income/yrQSR PortfolioQSR Income/yrGap
1← crossover$78,300$67,600.00$11,037$336.93+$67.3KOASMY
2$578,461$494,680.37$12,154$344.76+$566.3KOASMY
3$4,034,448$3,415,493.83$13,357$351.99+$4.02MOASMY
4$26,579,641$22,262,781.88$14,651$358.62+$26.56MOASMY
5$165,515,985$137,075,769.09$16,041$364.68+$165.50MOASMY
6$974,853,824$797,751,720.50$17,534$370.18+$974.84MOASMY
7$5,434,296,743$4,391,203,151.60$19,136$375.14+$5434.28MOASMY
8$28,691,936,121$22,877,238,605.16$20,856$379.58+$28691.92MOASMY
9$143,585,395,665$112,885,024,016.41$22,699$383.52+$143585.37MOASMY
10$681,598,738,880$527,962,365,518.27$24,675$386.99+$681598.71MOASMY

OASMY vs QSR: Complete Analysis 2026

OASMYStock

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.

Full OASMY Calculator →

QSRStock

Restaurant Brands International Inc. operates as quick service restaurant company in Canada and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and others. It is also involved in owning and franchising BK, a fast food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, french fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS restaurants quick service restaurants that offer subs, soft drinks, and local specialties. As of February 15, 2022, the company had approximately 29,000 restaurants in 100 countries under the Tim Hortons, Burger King, Popeyes, And Firehouse Subs brands. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Full QSR Calculator →
📬

Get this OASMY vs QSR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OASMY vs SCHDOASMY vs JEPIOASMY vs OOASMY vs KOOASMY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.